GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660)
₹ 2711 12.05 (0.45%) Market Cap: 459.26 Bil Enterprise Value: 440.88 Bil PE Ratio: 72.53 PB Ratio: 26.11 GF Score: 79/100

GlaxoSmithKline Pharmaceuticals Ltd Analyst Meeting Transcript

Aug 05, 2024 / NTS GMT
Ransom D;Souza
GlaxoSmithKline Pharmaceuticals Ltd - Executive Vice President - Communications and Government Affairs

' -

Good evening, everyone. And thank you for joining the call. In the room, we have our Managing director, Mr. Bhushan Akshikar. Some of you have interacted. Some of you have interacted with Bhushan earlier. Also, we have our CFO Juby Chandy. Without further ado, I'd hand it over to Bhushan, who will give you an introduction and also after that, followed by the financial slide presentation by Juby and post that we will open up for questions. (Event Instructions) Over to you.

Bhushan Akshikar
GlaxoSmithKline Pharmaceuticals Ltd - Managing Director, Executive Director

Thank you very much, Ransom.

So first of all any thanks to each one of you for taking our time to be on this call. As you must have seen in the results that were announced to the state on Friday last week, this is concluded Q1. But as we use the segue to talk about the financial numbers in a few minutes, I'll probably frame the context in the next five to six

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot